![]() |
||
|
Regular Member
![]() ![]() ¥[¤J¤é´Á: Oct 2008
¤å³¹: 50
|
®M¦b¥~±ªº¤f¸n"®M",¦³¨S¦³´c·dª©ªº°Ú? (¨Ò : °µÓ¹q¼v"²×·¥¾Ô¤h"¥~¬P¤Hªº"¼L¤Ú"¼Ë¦¡!)
¦n§a! §Ú©Ó»{«Ý¦b®a¦³ÂIµL²á! ¶Ãµo¤å! ![]() ¦¹¤å³¹©ó 2020-04-06 10:18 PM ³Q NT-MAN ½s¿è. |
|||||||
|
|
|
New Member
¥[¤J¤é´Á: Oct 2016
¤å³¹: 1
|
¤Þ¥Î:
¹Ãĸp¬O¦Û¤v¦³°µ¹L¹êÅç¤~±Ð¥Á²³³o¼Ë°µªº¡A°®»]¹L3~5¦¸¡A°ò¥»©Mªì©lª¬ºAªº¹LÂo²v®t¤£¦h https://www.edh.tw/article/23961 ¹Ãĸp¬ãÀ˲Õ²¥ô§Þ¥¿¤ý³ÕÅAªí¥Ü¡A¹qÁç°®»]¨ì100¢J®É·|¦Û°Ê¸õ°_¡A¦AÀR¸m5¤ÀÄÁ¡AÁ示ªº¼öªÅ®ð¥i¥H¥R¤À±þµß¡C¹Ãĸp´ú¸Õ¤F¤@¯ëÂå¥Î¤f¸n©M¥~¬ì¤f¸nµo²{¡A°®»]3¡ã5¦¸ªº¤f¸n¡A²Óµß¹LÂo®Ä²v¡]BFE¡^»P¥[¼ö«e´X¥G¨S¦³®t§O¡A¬Òºû«ù¦b99¢H¥H¤W¡C
__________________
µU¤l¡G§AÓ¥¯Ý¡A´ÛÄF§Ú·P±¡! |
|||
|
|
|
Major Member
![]() ¥[¤J¤é´Á: Sep 2001
¤å³¹: 263
|
¤Þ¥Î:
³oÓ¥i¥H¦Ò¼{ ![]() |
|
|
|
|
*°±Åv¤¤*
¥[¤J¤é´Á: Dec 2004
¤å³¹: 412
|
¤Þ¥Î:
¦³¨Ç¤H¥un¯à§è«á»L´N¦æ ºÞ¥L³ø¾É¼g¤°»ò ![]() |
|
|
|
|
Golden Member
![]() ![]() ![]() ![]() ¥[¤J¤é´Á: May 2001
¤å³¹: 3,372
|
³o¼Ë¤l §ÚÁÙn¥h¶R¤@ӶDzΪº¹qÁç¡C ![]()
__________________
µL¨}¦æ¬F¾÷Ãö ·s¥_¥«½Ã¥Í§½ ![]() ·s®ü¾ô¤U¨º´É¡C¥æ³q¤£¤è«KC Ghost island = §b¤Y Welcome to Taiwan! ![]()
|
|
|
|
Senior Member
![]() ![]() ![]() ¥[¤J¤é´Á: Apr 2017 ±zªº¦í§}: (¢£-_-)¢£ ~ ùäùä
¤å³¹: 1,428
|
¤Þ¥Î:
Ãø¹D©ú¤ÑÀY±ø: ¹qÁ礧¶Ã! ¸s²³¤j±ÆªøÀs·mÁʹqÁç¡I ![]()
__________________
------------------------------------------------------ ³o´N¬O Elon Musk Ãö°±USAIDªº¯u¬Û: COVID-19¬O¬ü°êUSAID³yªº¥Íª«ªZ¾¹ !!! ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ¢æ (Youtube¼v¤ù)§¹³J¤F¨S·dÀY¤F ³£¸Ó©Ç¦ò©_¦h¸Ü ---¦ò©_ªº¼v¤ù³ºµM³Q©Þ±¼? ¤F¸É¤W ¿ûÅK¤Hªº "DOGE" ¤£¿ù¬Ý! 1 2 3
|
|
|
|
|
Master Member
![]() ![]() ![]() ![]() ¥[¤J¤é´Á: Apr 2001 ±zªº¦í§}: °ª¶¯
¤å³¹: 2,247
|
¤f¸n®M§Ú¶R¤F¨âӨӥΡA¯u¤£¦æ¡C°£«D¾ã¤Ñ§¤¿ì¤½«Ç§j§N®ð¡C¤£µM¤S´e¤S¼ö¡A©I§l§xÃø¡C
«á¨Ó¶R¤F³æ¼h¤£Â´¥¬¤º¹Ñ¤ù¡A¦n¦h¤F¡A²{¦b¨C¤Ñ¥Î¡C ³Â¬Ù²z¤u³]p·s¤f¸n¡A¦³ N95 ¨¾Å@¤OÁÙ¥i®ø¬r«½Æ¨Ï¥Î ![]() ªñ´XÓ¤ë¡A³\¦h¬ü°êÂå°|¤w¶}©l¨Ï¥Î¹L®ñ¤Æ²B¡]H₂O₂¡^»]¨T¹ï N95 ¤f¸n¶i¦æ®ø¬r¡A³oÅý³æÓ¤f¸nªº¨Ï¥Î¦¸¼Æ¯à°÷¤W¤É¨ì 20 ¦¸¡A¦ý¬O®ø¬r¹Lµ{¤£¶È»Ýn¯S®í±M¥Î³]³Æ¡A§Y¨Ï±Ä¨ú¦¹¹Lµ{¡A¤@Ó¤f¸n¤]¥u¯àÀ¹¤@¤Ñ¡C ¬°¦¹¡AMIT ¹Î¶¤¨M©wµÛ¤â³]p¤@ºØ¥i¥H¦w¥þ®ø¬r¨Ã«½Æ¨Ï¥Îªº´À¥N«~¡CMIT ¾÷±ñ¤uµ{§U±Ð¡B¥¬µÜ®Ú°ü¤kÂå°|¸zG¬ìÂå¥Í Giovanni Traverso ªí¥Ü¡A¹Î¶¤ªº¥Ø¼Ð¬O¦p¦ó¡uº¡¨¬»Ý¨D¡v¡A¦]¦¹·s¤f¸n¥²¶·¥i¥H¶q²£¡AºÉ¥i¯à´£°ª«½Æ¨Ï¥Î©Ê¡A¦]¦¹³Ì¦n¯à¨Ï¥Î³\¦h¤£¦P¤è¦¡¶i¦æ®ø¬r¡C ¦b½Ñ¦h¦Ò¶q«á¡A¹Î¶¤³Ì²×¥H 3M 1860 «¬ N95 ¤f¸n§Îª¬¬°°ò¦¡A¨Ï¥Îª¿¾ó½¦¡]ª¿§Q±d¯N¹Ô¤¤¨Ï¥Îªº§÷®Æ¡^»s¦¨¤f¸n¦h¼Æ³¡¤À¡A¨ä¤¤ÁÙ¦³ªÅ¶¡¥i®e¯Ç 1-2 Ó N95 ¹LÂo¼h¡C ³q¹L¥i¥H§ó´«¹LÂo¼hªº³]p¡A¨Ï¥ÎªÌ¤£»Ýn¦A¥á±¼¾ãÓ¤f¸n¡A¶È»Ý®ø¬rª¿¾ó½¦¤f¸n¥»Åé¨Ã§ó´«¹LÂo¼h§Y¥i¡C¦b®ø¬r¤è±¡A¬ã¨s¤Hû¤]´ú¸Õ¤F¼ÆºØ·Àµß¤èªk¡A¥]¬A°ªÀ£·Àµß¡B©ñ¤J¯N½c©Î®ûªw¦bº}¥Õ¾¯©M²§¤þ¾J¤¤¡Aµ²ªGÅã¥Ü·s¤f¸n§÷®Æ§¡µL¨ü·l¡C ®Ú¾ÚÂåÀø«O°·¤u§@ªÌªº¤ÏõX¡A¸Ó¤p²Õ¥Ø«e¥¿¦b¬ã¨s§ï¨}ª©ªº¤f¸n¡A§Æ±æ·sª©¥»¯à§ó¥[µÎ¾A@¥Î¡A¹Î¶¤p¹º¦¨¥ß¤½¥q¨Ó¤ä«ùÂX¤j³W¼Ò¥Í²£¡A¦P®É¤]´M¨D FDA ©M¬ü°ê°ê®a¾·~¦w¥þ½Ã¥Í¬ã¨s©Ò¡]NIOSH¡^ªº»{¥i¡C ¾¨ºÞ¤@¨Ç°ê®a¬Ì±¡¤w³vº¥Áͽw¡A¦ý³\¦h°ê®a¯f¨Ò¼Æ¤´«ùÄò¼W¥[¡AN95 ¤f¸n¯îªº°ÝÃD¤´¥¼¸Ñ¨M¡A¬ã¨s§@ªÌ James Byrne ªí¥Ü¡A¥¿¦p¤j®a©Ò·Qªº¨º¼Ë¡A¦b¬Ì]¥X²{¥H«e¡AªZº~ªÍª¢³£µLªk¯u¥¿®ø¥¢¡C ¡u¦b§Ú¬Ý¨Ó¡AµL½×¬O¦bÂåÀø³õ©ÒÁÙ¬O¦b¤½¦@³õ¦X¡A¤HÌ©l²×³£»Ýn¤f¸n¡C¡v --- ³oª±·N¨à¬Ý°_¨Ó¤£¿ù¡A§Æ±æ¯à§ÖÂI¤W¥«¡Cªì´Á¤@©w¸û¶Q¡A¦ý¤j¶q¥Í²£ªº¸Ü»ù¿úÀ³¥iÀ£§C¡C
__________________
ñ¦WÀɯu¬Oê²´¡KÁÙ¬OÅýª©±°®²bÂI§a¡I |
|
|